H1B Report
Side-by-side comparison

ICON Clinical Research, LLC vs INFOSYS LIMITED

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
ICON Clinical Research, LLC
PARank #FEIN 23-2689156
Entity B
INFOSYS LIMITED
TXRank #1FEIN 58-1760235

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricICON Clinical Research, LLCINFOSYS LIMITED
Total filings172205,263
Certified %81.40%99.55%
Denied %1.74%0.21%
Withdrawn %2.33%0.20%
Cert-withdrawn %14.53%0.05%
Rank#1
Active yearsFY2010–FY2026FY2010–FY2026
Worksite statePATX

Outcomes — ICON Clinical Research, LLC

DOL case-status mix.

Outcome breakdown: Certified 81.4%, Cert-withdrawn 14.5%, Withdrawn 2.3%, Denied 1.7%
Outcome breakdown
OutcomeShare
Certified81.4%
Cert-withdrawn14.5%
Withdrawn2.3%
Denied1.7%
Certified81.4%
Cert-withdrawn14.5%
Withdrawn2.3%
Denied1.7%

Outcomes — INFOSYS LIMITED

DOL case-status mix.

Outcome breakdown: Certified 99.5%, Cert-withdrawn 0.0%, Withdrawn 0.2%, Denied 0.2%
Outcome breakdown
OutcomeShare
Certified99.5%
Cert-withdrawn0.0%
Withdrawn0.2%
Denied0.2%
Certified99.5%
Cert-withdrawn0.0%
Withdrawn0.2%
Denied0.2%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

ICON Clinical Research, LLC
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY201010
FY201116
FY201216
FY201315
FY20148
FY201516
FY201618
FY201717
FY201818
FY20197
FY20201
FY20210
FY20221
FY20237
FY202411
FY20258
FY20263
INFOSYS LIMITED
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,164
FY20111,681
FY201214,701
FY201332,232
FY201423,749
FY201533,214
FY201625,335
FY201720,571
FY201811,569
FY201921,420
FY202016
FY202129
FY202222
FY20232,269
FY20245,943
FY20255,790
FY20264,558

Top 5 occupations — ICON Clinical Research, LLC

Top 5 occupations — INFOSYS LIMITED

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.